Venbio Partners Llc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value

$280.6M

Q ending 2026-03-31

Prior quarter

$216.3M

Q ending 2025-12-31

Change

+29.7% QoQ · +127.1% YoY

Positions

reported holdings

Largest positions

All 6 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.

Holding	Ticker	Type	Value ▼	Shares
Pharvaris N V		Shares	$131.1M	4.6M
Alumis Inc	ALMS	Shares	$99.8M	4.5M
Alx Oncology Hldgs Inc	ALXO	Shares	$25.8M	12.9M
Harmony Biosciences Hldgs In	HRMY	Shares	$13.7M	489K
Lyell Immunopharma Inc	LYEL	Shares	$6.8M	338K
Artiva Biotherapeutics Inc	ARTV	Shares	$3.4M	531K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.